PL2496241T3 - Sposoby zmniejszania stanu zapalnego przewodu pokarmowego z zastosowaniem bakterii Bifidobacterium animalis albo fermentowanego produktu nabiałowego obejmującego takie bakterie - Google Patents

Sposoby zmniejszania stanu zapalnego przewodu pokarmowego z zastosowaniem bakterii Bifidobacterium animalis albo fermentowanego produktu nabiałowego obejmującego takie bakterie

Info

Publication number
PL2496241T3
PL2496241T3 PL09805954T PL09805954T PL2496241T3 PL 2496241 T3 PL2496241 T3 PL 2496241T3 PL 09805954 T PL09805954 T PL 09805954T PL 09805954 T PL09805954 T PL 09805954T PL 2496241 T3 PL2496241 T3 PL 2496241T3
Authority
PL
Poland
Prior art keywords
bacteria
dairy product
fermented dairy
bifidobacterium animalis
intestinal inflammation
Prior art date
Application number
PL09805954T
Other languages
English (en)
Inventor
Patrick Veiga
Isabelle Chambaud
Artem Khlebnikov
Laurie H Glimcher
Wendy S Garrett
Original Assignee
Gervais Danone Sa
The President And Fellows Of Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa, The President And Fellows Of Harvard College filed Critical Gervais Danone Sa
Publication of PL2496241T3 publication Critical patent/PL2496241T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09805954T 2009-11-02 2009-11-02 Sposoby zmniejszania stanu zapalnego przewodu pokarmowego z zastosowaniem bakterii Bifidobacterium animalis albo fermentowanego produktu nabiałowego obejmującego takie bakterie PL2496241T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09805954.6A EP2496241B1 (en) 2009-11-02 2009-11-02 Method for reducing gastro-intestinal inflammation using bifidobacterium animalis bacteria or a fermented dairy product comprising such bacteria
PCT/IB2009/056007 WO2011051760A1 (en) 2009-11-02 2009-11-02 Method for reducing gastro-intestinal inflammation using bifidobacterium animalis bacteria or a fermented dairy product comprising such bacteria

Publications (1)

Publication Number Publication Date
PL2496241T3 true PL2496241T3 (pl) 2014-03-31

Family

ID=42102362

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09805954T PL2496241T3 (pl) 2009-11-02 2009-11-02 Sposoby zmniejszania stanu zapalnego przewodu pokarmowego z zastosowaniem bakterii Bifidobacterium animalis albo fermentowanego produktu nabiałowego obejmującego takie bakterie

Country Status (8)

Country Link
US (1) US8685388B2 (pl)
EP (1) EP2496241B1 (pl)
CN (1) CN102711778B (pl)
BR (1) BR112012010398A2 (pl)
EA (1) EA021890B1 (pl)
ES (1) ES2436620T3 (pl)
PL (1) PL2496241T3 (pl)
WO (1) WO2011051760A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
US9814756B2 (en) 2012-06-15 2017-11-14 Temple University—Of the Commonwealth System of Higher Education Use of isolated bacterial amyloids for treatment of inflammatory disorders or diseases of the epithelium
WO2014096901A1 (en) * 2012-12-18 2014-06-26 Compagnie Gervais Danone Strain of bifidobacterium animalis ssp. animalis
BR112015014693A2 (pt) * 2012-12-20 2017-10-10 Gervais Danone Sa uso de bifidobacterium animalis para o tratamento ou a prevenção de ganho de peso corpóreo e resistência à insulina
RU2725883C2 (ru) * 2015-04-23 2020-07-07 Компани Жервэ Данон Композиция для сокращения выработки кишечного газа
CA2995786A1 (en) * 2015-08-24 2017-03-02 Nubyiota Llc Systems and methods for treating a dysbiosis using fecal-derived bacterial populations
CN107574133A (zh) * 2017-05-05 2018-01-12 南昌大学 动物双歧杆菌m2017064及其在缓解慢性肾脏疾病药物的应用
US20190298783A1 (en) * 2018-03-28 2019-10-03 Morinaga Milk Industry Co., Ltd. Composition for relieving stress, pharmaceutical composition and food and drink composition and method for relieving stress using the composition for relieving stress
WO2020102472A1 (en) * 2018-11-15 2020-05-22 President And Fellows Of Harvard College Methods and compositions related to targeting ffar2 and ilc3 populations for the treatment of a gastrointestinal disease
TWI754302B (zh) * 2019-06-21 2022-02-01 大江生醫股份有限公司 乳雙歧桿菌tci604及其代謝產物的應用
IT201900016811A1 (it) * 2019-09-20 2021-03-20 Sofar Spa Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali
CN113430133B (zh) * 2021-06-24 2023-06-23 微康益生菌(苏州)股份有限公司 一种能够缓解溃疡性结肠炎的复合益生菌、制备方法及其应用
CN113368139A (zh) * 2021-07-02 2021-09-10 微康益生菌(苏州)股份有限公司 一种具有缓解肠易激综合征功效的微生物复合物及其制备方法和应用
CN113736697B (zh) * 2021-09-01 2022-05-24 哈尔滨葵花药业有限公司 一株预防或治疗结肠炎的乳双歧杆菌及其应用
CN115363094A (zh) * 2021-11-30 2022-11-22 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99在预防和/或改善胃炎中的应用
CN117264853B (zh) * 2023-11-17 2024-02-27 中国农业大学 一种缓解溃疡性结肠炎的富硒动物双歧杆菌h15的筛选方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811333B1 (fr) 2000-07-04 2003-01-10 Gervais Danone Sa Microorganismes ayant une action modulatrice de la glycosylation de surface des cellules intestinales et methode de selection desdits microorganismes
CN102336832A (zh) * 2004-11-25 2012-02-01 荷兰联合利华有限公司 重链和结构域抗体
ZA200800308B (en) * 2005-07-20 2009-08-26 Unilever Plc Edible product containing beneficial bacteria
US20090110663A1 (en) * 2007-10-24 2009-04-30 Halow George M Method for treatment of bowel disorders
ES2395838T3 (es) * 2007-12-21 2013-02-15 Compagnie Gervais Danone Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium
US20090238796A1 (en) * 2008-03-24 2009-09-24 Tamara Vasilevna Maculevich Preparation for treatment of non-infectious inflammatory intestinal diseases

Also Published As

Publication number Publication date
EP2496241B1 (en) 2013-08-28
US8685388B2 (en) 2014-04-01
WO2011051760A1 (en) 2011-05-05
ES2436620T3 (es) 2014-01-03
EA201200689A1 (ru) 2012-09-28
EP2496241A1 (en) 2012-09-12
CN102711778A (zh) 2012-10-03
EA021890B1 (ru) 2015-09-30
US20120308523A1 (en) 2012-12-06
CN102711778B (zh) 2015-06-24
BR112012010398A2 (pt) 2016-07-12

Similar Documents

Publication Publication Date Title
PL2496241T3 (pl) Sposoby zmniejszania stanu zapalnego przewodu pokarmowego z zastosowaniem bakterii Bifidobacterium animalis albo fermentowanego produktu nabiałowego obejmującego takie bakterie
HK1217411A1 (zh) 乳製品及方法
HK1167577A1 (en) Method for alleviating intestinal problems and novel bacterial strains therefor
IL219403A0 (en) Whey protein product and a method for its preparation
EP2148577A4 (en) DAIRY PRODUCT AND PROCESS
SG175167A1 (en) Growing up milks containing probiotic micro-organisms
IL216447A (en) Process for making fermented milk product
IL199927A (en) Drinking yogurt and its preparation process
ZA201001030B (en) Dairy product and process
EP2112219A4 (en) NEW LACTIC ACID BACTERIA
HK1122960A1 (en) A fermented dairy product and the method for producing the same
ZA201105741B (en) Methods for isolating bacteria
EP2294926A4 (en) PROCESS FOR THE PRODUCTION OF FERMENTED MILK AND FERMENTED MILK
HK1151695A1 (en) Novel fermented milk product and use thereof
PL2582787T3 (pl) Bakterie kwasu mlekowego do jogurtu
HRP20190499T1 (hr) Proizvod koji sadrži bakterije mliječne kiseline i sušilo
HK1165224A1 (en) A method for producing a fermented milk product
EP2146585A4 (en) DAIRY PRODUCT AND WHOLESALE EXPERIENCES
EP2149309A4 (en) FERMENTED FOOD / DRINK AND METHOD FOR THE PRODUCTION THEREOF
EP2647294A4 (en) PROCESS FOR THE PRODUCTION OF FERMENTED FOOD CONTAINING BIFIDOBACTERIUM BACTERIA
IL187645A0 (en) Process for preparing bakeable probiotic food
HK1163173A1 (en) Method for culturing lactic acid bacterium and method for producing fermented milk
ZA201008282B (en) Systems and methods for producing reduced cholesterol dairy products
EP2222173A4 (en) MILK PRODUCT AND ASSOCIATED METHOD
ZA201107801B (en) Fermented soy-based food product